Erudio Healtherudio.com
Drug
Silevertinib trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying silevertinib: BDTX-1535-101. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| BDTX-1535-101 NCT05256290 · Black Diamond Therapeutics, Inc. | EGFR-mutated NSCLC or glioblastoma | Phase 1/Phase 2 | 37 | 12 | Focused | Nov 20, 2026 | Preview |